What is Immco Diagnostics?
Founded in 1971 and headquartered in Buffalo, New York, Immco Diagnostics, Inc. (IMMCO) stands as a global leader in autoimmune diagnostics services and the manufacturing and distribution of medical devices. With a deep-seated commitment to research and development, IMMCO leverages cutting-edge methodologies to diagnose a broad spectrum of diseases. The company has consistently focused on technological advancement, with plans to introduce proprietary technologies in the 2005-2006 period aimed at expanding the frontiers of autoimmunity and further distinguishing its offerings from international competitors.
How much funding has Immco Diagnostics raised?
Immco Diagnostics has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
What's next for Immco Diagnostics?
The recent major strategic investment indicates a pivotal moment for Immco Diagnostics, likely signaling a phase of accelerated growth, market expansion, or the development and commercialization of new diagnostic technologies. This capital will empower the company to further its R&D initiatives, enhance its manufacturing capabilities, and solidify its market leadership in autoimmune diagnostics. The strategic nature of the investment suggests a strong alignment between IMMCO and its backers regarding future market opportunities and technological innovation.
See full Immco Diagnostics company page
